Switzerland· 59764001
Imipenem-Cilastatin Labatec, poudre pour solution pour perfusion
A imipenem and cilastatin product containing imipenemum anhydricum, cilastatinum, registered in Switzerland by Labatec Pharma SA and dispensed under Swissmedic category A. The same ATC class is registered in 12 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Imipenem and cilastatin is registered in 12 of 19 countries.
Countries holding a registration under ATC J01DH51 (imipenem and cilastatin), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Imipenem and cilastatin · ATC J01DH51
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- imipenemum anhydricum, cilastatinum
- Manufacturer
- Labatec Pharma SA
- Country
- Switzerland (CH)
- ATC code
- J01DH51
- ATC class
- Imipenem and cilastatin
- Defined daily dose
- 2 g, P
- Swissmedic category
- A
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for imipenem and cilastatin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Imipenem and cilastatin · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under J01DH51
Imipenem and cilastatin, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ed9909c9-7020-4f33-a5b4-ea520f231d68 GET /v1/drugs/ed9909c9-7020-4f33-a5b4-ea520f231d68?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about imipenem and cilastatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.